ArticleScientific reports2026

Use of mesenchymal stromal cells derived from the Wharton's jelly of human umbilical cord for treating patients with steroid-resistant graft versus host disease: predicting clinical response by a validated immunopotency assay.

Silvia Torrents et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.